Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method ...

This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...

The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits) ...

FRANKFURT, Jan 30 (Reuters) - Roche (ROG.S), opens new tab said on ... would mark continued earnings momentum as the Swiss drugs and diagnostics company said in its earnings statement that ...

This gene-editing tool has been adapted for molecular diagnostics, utilizing Cas proteins to detect specific nucleic acid sequences with high sensitivity. CRISPR-based platforms such as SHERLOCK ...